Mortgage Marketshare Module
- Accurately track commercial and residential lending, measure sales performance against competition and market activity, identify high-performing competitors, and locate and target emerging markets.
  
  LEARN MORE >>
Loan Originator Module
- Access the largest and most comprehensive mortgage loan origination database in New England with round-the-clock interactive access and weekly trend updates.
  
  LEARN MORE >>
Marketing Lists
- Gain access to the most accurate and detailed transaction information in the country and offers a range of marketing lists for more than 130 million households (covering 94% of the U.S. population).
  
  LEARN MORE >>
Custom Research
- Powered by one-of-a-kind real estate, mortgage, and loan origination data, The Warren Group provides custom solutions for your research projects, database expansion, and strategic planning.
  
  LEARN MORE >>
Real Estate Records Search
- Access the largest and most complete real estate database in New England, including sales, price trends, liens and foreclosures.
  
  LEARN MORE >>

Biopharma Company Expands Lease in Stamford

September 23, 2020 | Reprints | Unlock Link | Print

Cara Therapeutics Inc. will expand into more than 11,000 square feet in its current location.

The company moved its headquarters to 107 Elm St. in Stamford in 2016. The expansion into an adjacent 11,685-square-foot space “presented the best opportunity to keep the company’s existing office in a prime building with an excellent location,” brokerage Choyce Peterson said in a statement.

Cara was represented by Choyce Peterson Principal John Hannigan and Vice President Adam Cognetta in this transaction.

Cara Therapeutics is a clinical-stage biopharmaceutical company that develops “new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors,” according to its website.